October was the month shorts made all out war on adxs share price..a small biotech with less than 200 million market cap..nothing more than a grain of sand on the biotech beach..but the subject of intense and coordinated pps attack..there are dozens of small bios under 200 million market cap..why is adxs so special to receive this kind of attention from very powerful financial interests..10 million short shares trying to sabotage the commercialization of revolutionary cancer treatment..i have waited, i am waiting and i shall wait.
News 
Market Data 
Discover 
